Posted: 29 May 2013 02:00 PM PDT
Amgen (NASDAQ:AMGN), the world's largest independent biotechnology company, and Astellas Pharma Inc. (Tokyo Stock Exchange: 4503, "Astellas"), a leading Tokyo-based global pharmaceutical company, announced the companies have entered into a strategic alliance to provide new medicines to help address serious unmet medical needs of Japanese patients.